Skip to search formSkip to main contentSkip to account menu

azelnidipine

Known as: 3,5-Pyridinedicarboxylic acid, 2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-, 3-(1-(diphenylmethyl)-3-azetidinyl) 5-(1-methylethyl) ester, (+-)-, 3-(1-diphenylmethylazetidin-3-yl)-5-isopropyl-2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Objective: Azelnidipine, a long-acting dihydropyridine based calcium channel blocker, on oral administration, the drug undergoes… 
2012
2012
The invention relates to a preparation method of azelnidipine as a dihydropyridine calcium channel blocker, belonging to the… 
2012
2012
Objective To verify the feasibility and reliability for the pilot process of Azelnidipine Tablets by this test.Methods The… 
2009
2009
(+)-Dapoxetine hydrochloride; Abatacept, Adalimumab, Agalsidase beta, Alemtuzumab, Alglucosidase alfa, Aliskiren fumarate… 
2008
2008
OBJECTIVE To establish an HPLC method for determination of content in Azelnidipine Tablets.METHODS The HPLC system consisted of a… 
2007
2007
Objective:To synthesize azenidipine.Methods:Azelnidipine was prepared from benzhydrylamine via addition,esterifieation,aeidation… 
2006
2006
OBJECTIVE To establish an HPLC method for determination of content and related substances in Azelnidipine tablets and capsules… 
2005
2005
  • 2005
  • Corpus ID: 264027426
1999
1999
: Azelnidipine (CS-905) is a long-acting, once-daily, orally-administered calcium channel antagonist which is being jointly…